The forecast for cardiovascular system medicine use in Denmark shows a consistent increase from 2024 to 2028. The Defined Daily Dosage (DDD) per thousand persons per day is anticipated to rise from 727.4 in 2024 to 819.0 in 2028.
Year-on-year variations indicate a steady growth with the following annual increases:
- 2024 to 2025: 3.3%
- 2025 to 2026: 3.1%
- 2026 to 2027: 2.9%
- 2027 to 2028: 2.8%
The Compound Annual Growth Rate (CAGR) over the five-year forecast period is approximately 3.0%.
Future trends to watch for include advancements in cardiovascular treatments, shifts in healthcare policies, the aging population, and lifestyle changes affecting cardiovascular health. These factors will likely intensify the demand for cardiovascular medications in Denmark.
